Richard C. Dinovitz serves as a member on the Board of Directors at ADVAITE. Richard received his B.S degree from the University of Pittsburgh. Currently, Chief Commercial Officer and Executive Vice Presdent of Sales and Business Development and Board member, NextSource Biotechnology, Richard mobilizes teams to exceed corporate goals while leading by example. Richard is currently the President and COO of RCDVaccine, LLC and the Owner of Vaccine Business Logistics. Richard is an officer level executive with extensive leadership success working in complex Fortune 500 companies in the pharmaceutical industry in functional roles of strategic sales; marketing; specialty; vaccine and biological, oncological and anti-infective product marketing; business development; sales management; and commercial operations. Demonstrated ability to deliver strong and sustainable financial gains through building high performing teams, identifying and capitalizing on business and product specification opportunities, expanding distribution channels, successful launching of new products, and developing innovative marketing strategies. Richard was Executive Director, National Sales, at PFIZER – SPECIALTY CARE (formerly Wyeth) from 2000 – 2010. Prior to Wyeth, Richard had been with Lederle Laboratories for 16 years in various, increasingly responsible Sales Management positions − his last two roles being Senior Sales Manager, Corporate Trade Relations and National Account Sales Manager. He received training at Certified Medical Representative Institute, is a Member of the Cardinal Advisory Board, and an active participant in NACDS, HDMA, FMI trade associations.
Christine Mun serves as the Communications Director at ADVAITE. In this role, she sets and guides the strategy for all communications, website, and public relations messages to consistently articulate the ADVAITE mission. Christine graduated from Loyola University in Chicago with Bachelors in Biological sciences. Following graduation, she joined the Department of Ophthalmology at University of Illinois at Chicago (UIC) as Clinical Research Coordinator and led the implementation of a NEI/National Institutes of Health funded phase I/II clinical trials as well as several Industry Sponsored Trials. Christine has participated in the FDA Pre-Investigational New Drug Application (PIND) meetings to discuss the development plans for an orphan drug. She leads the organizational activities of a national-level meeting in ocular GVHD that receives funding from NEI/NIH. Her continuing education includes membership of Society of Clinical Research Associates (SOCRA) and participation in FDA Clinical Trial Requirements, Regulations, Compliance and GCP symposiums. Christine also serves as the Assistant Director of the Dry Eye & ocular GVHD Clinic at UIC, where she provides strategic direction to the clinical care of patients with ocular surface diseases. She has authored numerous presentations regarding pathology of eye diseases at the annual meetings of Association for Research in Vision and Ophthalmology (ARVO) of which she is a member. Christine has served in humanitarian efforts in Mozambique, Uganda, South Africa and Mexico. Christine’s goal is to make a difference in the lives of people by her empathic and conscientious efforts to find solutions to the unmet medical and social needs.